Pain after craniotomy: A time for reappraisal?
Indian Journal of Pain · 2013
DOI: 10.4103/0970-5333.114853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pain, 2013. Verfasst von Suman Chattopadhyay und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Until recently, perioperative pain management in neurosurgical patients has been inconsistently recognized and inadequately treated. An increased awareness of pain management in general along with advances in the understanding of pain modulation and pathophysiology, has led to improved practice and perioperative care of patients following craniotomy. Otherwise, severe postoperative pain impairs the quality of recovery and causes emotional distress with the possibility of inducing chronic pain and lasting functional deficits. The greatest challenge in managing neurosurgical patients is the need to assess the neurological function while providing superior analgesia with minimal side effects. To achieve this goal, a multimodal approach to analgesia, using various drugs and techniques, is advocated. There still remains a need, however, to conduct further randomized, controlled trials, to determine the best combination of drugs or techniques for treating perioperative pain in this patient population. Improved awareness, assessment, and treatment of pain result in better care and overall patient outcome.
Zitieren
APA
Chattopadhyay, S., Saha, P., Rudra, A., & Roy, S. (2013). Pain after craniotomy: A time for reappraisal?. Indian Journal of Pain. https://doi.org/10.4103/0970-5333.114853
Vancouver
Chattopadhyay S, Saha P, Rudra A, Roy S. Pain after craniotomy: A time for reappraisal?. Indian Journal of Pain. 2013. doi:10.4103/0970-5333.114853
BibTeX
@article{Chattopadhyay2013,
author = {Chattopadhyay, Suman and Saha, Pradipta and Rudra, A and Roy, Sourabh},
title = {Pain after craniotomy: A time for reappraisal?},
journal = {Indian Journal of Pain},
year = {2013},
doi = {10.4103/0970-5333.114853}
}
EUVIMED